These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24650707)

  • 1. Historical experience in the elimination of visceral leishmaniasis in the plain region of Eastern and Central China.
    Guan LR; Wu ZX
    Infect Dis Poverty; 2014 Mar; 3(1):10. PubMed ID: 24650707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge, attitudes, and practices about kala-azar and its sandfly vector in rural communities of Nepal.
    Koirala S; Parija SC; Karki P; Das ML
    Bull World Health Organ; 1998; 76(5):485-90. PubMed ID: 9868839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insecticide resistance in phlebotomine sandflies in Southeast Asia with emphasis on the Indian subcontinent.
    Dhiman RC; Yadav RS
    Infect Dis Poverty; 2016 Nov; 5(1):106. PubMed ID: 27817749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmaniasis in Sudan. Visceral leishmaniasis.
    Zijlstra EE; el-Hassan AM
    Trans R Soc Trop Med Hyg; 2001 Apr; 95 Suppl 1():S27-58. PubMed ID: 11370250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenodiagnosis to evaluate the infectiousness of humans to sandflies in an area endemic for visceral leishmaniasis in Bihar, India: a transmission-dynamics study.
    Singh OP; Tiwary P; Kushwaha AK; Singh SK; Singh DK; Lawyer P; Rowton E; Chaubey R; Singh AK; Rai TK; Fay MP; Chakravarty J; Sacks D; Sundar S
    Lancet Microbe; 2021 Jan; 2(1):e23-e31. PubMed ID: 33615281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kala-azar elimination in a highly-endemic district of Bihar, India: A success story.
    Kumar V; Mandal R; Das S; Kesari S; Dinesh DS; Pandey K; Das VR; Topno RK; Sharma MP; Dasgupta RK; Das P
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008254. PubMed ID: 32365060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of eliminating visceral leishmaniasis from the Indian subcontinent: explorations with a set of deterministic age-structured transmission models.
    Le Rutte EA; Coffeng LE; Bontje DM; Hasker EC; Postigo JA; Argaw D; Boelaert MC; De Vlas SJ
    Parasit Vectors; 2016 Jan; 9():24. PubMed ID: 26787302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lost hope of elimination of Kala-azar (visceral leishmaniasis) by 2010 and cyclic occurrence of its outbreak in India, blame falls on vector control practices or co-infection with human immunodeficiency virus or therapeutic modalities?
    Muniaraj M
    Trop Parasitol; 2014 Jan; 4(1):10-9. PubMed ID: 24754021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination.
    Kumar A; Singh VK; Tiwari R; Madhukar P; Rajneesh ; Kumar S; Gautam V; Engwerda C; Sundar S; Kumar R
    Front Immunol; 2023; 14():1236952. PubMed ID: 37638047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal leishmaniasis.
    Chapman LAC; Spencer SEF; Pollington TM; Jewell CP; Mondal D; Alvar J; Hollingsworth TD; Cameron MM; Bern C; Medley GF
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25742-25750. PubMed ID: 32973088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological features and spatial-temporal clustering of visceral leishmaniasis in mainland China from 2019 to 2021.
    Li Y; Luo Z; Hao Y; Zhang Y; Yang L; Li Z; Zhou Z; Li S
    Front Microbiol; 2022; 13():959901. PubMed ID: 36106082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of treatment outcomes of visceral leishmaniasis (VL) treated cases and impact of COVID-19 on VL management and control services in Bangladesh.
    Maruf S; Sagar SK; Rashid MU; Uddin MR; Ghosh D; Ghosh P; Nath R; Sohel ANM; Aktaruzzaman MM; Islam MN; Banjara MR; Kroeger A; Aseffa A; Mondal D
    J Infect Public Health; 2023 Nov; 16(11):1716-1721. PubMed ID: 37741011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological, serological, and entomological aspects of visceral leishmaniasis (VL) in suspected new VL foci in Bangladesh.
    Ghosh D; Rashid MU; Sagar SK; Uddin MR; Maruf S; Ghosh P; Chowdhury R; Rahat MA; Islam MN; Aktaruzzaman MM; Sohel ANM; Banjara MR; Kroeger A; Aseffa A; Mondal D
    Acta Trop; 2023 Dec; 248():107021. PubMed ID: 37716668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.
    Hossain MS; Kumar A; Hossain AFMA; Mahshin M; Sharma A; Hossain MA; Sharma V; Haque R; Shamsuzzaman AKM; Maruf S; Ghosh P; Ahuja V; Mondal D
    Infect Dis Poverty; 2018 Aug; 7(1):80. PubMed ID: 30099967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological features and spatial-temporal distribution of visceral leishmaniasis in mainland China: a population-based surveillance study from 2004 to 2019.
    Guan Z; Chen C; Huang C; Zhang H; Zhou Y; Zhou Y; Wu J; Zhou Z; Yang S; Li L
    Parasit Vectors; 2021 Oct; 14(1):517. PubMed ID: 34620225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indoor residual spraying for kala-azar vector control in Bangladesh: A continuing challenge.
    Chowdhury R; Chowdhury V; Faria S; Islam S; Maheswary NP; Akhter S; Islam MS; Dash AP; Kroeger A; Banu Q
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006846. PubMed ID: 30273402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse.
    Mondal D; Ghosh P; Chowdhury R; Halleux C; Ruiz-Postigo JA; Alim A; Hossain F; Khan MAA; Nath R; Duthie MS; Kroeger A; Matlashewski G; Argaw D; Olliaro P
    Front Microbiol; 2019; 10():2268. PubMed ID: 31649631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of visceral leishmaniasis in Bangladesh: prospects for improved control.
    Bern C; Chowdhury R
    Indian J Med Res; 2006 Mar; 123(3):275-88. PubMed ID: 16778310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of smear examination, culture, and serological tests in the diagnosis of visceral leishmaniasis/post-kala-azar dermal leishmaniasis at National Centre for Disease Control, Delhi.
    Singhai M; Kakkar N; Gupta N; Bala M; Singh R; Singh SK
    Trop Parasitol; 2022; 12(1):54-58. PubMed ID: 35923261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India.
    Das VNR; Siddiqui NA; Bhunia GS; Pandey K; Sinha SK; Ansari MZ; Topno RK; Lal CS; Ranjan A; Singh VP; Das P
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009598. PubMed ID: 34428232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.